TheraRadar
← Back
Data updated: Mar 29, 2026

EUGIA PHARMA SPECLTS

Infectious DiseaseOncologyDermatology
Generics

EUGIA PHARMA SPECLTS is a generic drug manufacturer focused on Infectious Disease, Oncology, Dermatology.

2002
Since
14
Drugs
-
Trials
132
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

AMPICILLIN AND SULBACTAM 2026-02-17
Labeling
AMPICILLIN AND SULBACTAM 2026-02-17
Labeling
AMPICILLIN AND SULBACTAM 2026-02-17
Labeling
AMPICILLIN AND SULBACTAM 2026-02-17
Labeling
AMPICILLIN AND SULBACTAM 2026-02-17
Labeling
AMPICILLIN AND SULBACTAM 2026-02-17
Labeling
AMPICILLIN AND SULBACTAM 2026-02-17
Labeling
FLUOROURACIL 2026-02-10
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 33%
3 drugs
Oncology 33%
3 drugs
Dermatology 11%
1 drugs
Gastroenterology 11%
1 drugs
Immunology 11%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Pfizer big-pharma
Oncology, Infectious Disease, Dermatology, Immunology, Gastroenterology
Bristol-Myers Squibb big-pharma
Oncology, Immunology, Gastroenterology, Infectious Disease
COSETTE other
Dermatology, Infectious Disease, Immunology, Oncology
Merck big-pharma
Oncology, Infectious Disease, Immunology
Baxter specialty
Infectious Disease, Oncology, Dermatology